Ghatge Madankumar, Flora Gagan D, Nayak Manasa K, Chauhan Anil K
Department of Internal Medicine, Division of Hematology/Oncology, University of Iowa.
Arterioscler Thromb Vasc Biol. 2024 Feb;44(2):409-416. doi: 10.1161/ATVBAHA.123.319821. Epub 2023 Nov 9.
Evolving evidence suggests that besides signaling pathways, platelet activation involves a complex interplay between metabolic pathways to support thrombus growth. Selective targeting of metabolic checkpoints may inhibit platelet activation and provide a novel antiplatelet strategy. We, therefore, examined global metabolic changes that occur during the transition of human platelets from resting to an activated state to identify metabolites and associated pathways that contribute to platelet activation.
We performed metabolic profiling of resting and convulxin-stimulated human platelet samples. The differential levels, pathway analysis, and PCA (principal component analysis) were performed using Metaboanalyst. Metascape was used for metabolite network construction.
Of the 401 metabolites identified, 202 metabolites were significantly upregulated, and 2 metabolites were downregulated in activated platelets. Of all the metabolites, lipids scored highly and constituted ≈50% of the identification. During activation, aerobic glycolysis supports energy demand and provides glycolytic intermediates required by metabolic pathways. Consistent with this, an important category of metabolites was carbohydrates, particularly the glycolysis intermediates that were significantly upregulated compared with resting platelets. We found that lysophospholipids such as 1-palmitoyl-GPA (glycero-3-phosphatidic acid), 1-stearoyl-GPS (glycero-3-phosphoserine), 1-palmitoyl-GPI (glycerophosphoinositol), 1-stearoyl-GPI, and 1-oleoyl-GPI were upregulated in activated platelets. We speculated that platelet activation could be linked to 1-carbon metabolism, a set of biochemical pathways that involve the transfer and use of 1-carbon units from amino acids, for cellular processes, including nucleotide and lysophospholipid synthesis. In alignment, based on pathway enrichment and network-based prioritization, the metabolites from amino acid metabolism, including serine, glutamate, and branched-chain amino acid pathway were upregulated in activated platelets, which might be supplemented by the high levels of glycolytic intermediates.
Metabolic analysis of resting and activated platelets revealed that glycolysis and 1-carbon metabolism are necessary to support platelet activation.
越来越多的证据表明,除了信号通路外,血小板激活还涉及代谢途径之间的复杂相互作用以支持血栓形成。选择性靶向代谢检查点可能抑制血小板激活并提供一种新的抗血小板策略。因此,我们研究了人类血小板从静息状态转变为激活状态期间发生的整体代谢变化,以确定有助于血小板激活的代谢物和相关途径。
我们对静息和convulxin刺激的人类血小板样本进行了代谢谱分析。使用Metaboanalyst进行差异水平、途径分析和主成分分析(PCA)。Metascape用于构建代谢物网络。
在鉴定出的401种代谢物中,202种代谢物在激活的血小板中显著上调,2种代谢物下调。在所有代谢物中,脂质得分很高,占鉴定的约50%。在激活过程中,有氧糖酵解支持能量需求并提供代谢途径所需的糖酵解中间体。与此一致的是,一类重要的代谢物是碳水化合物,特别是与静息血小板相比显著上调的糖酵解中间体。我们发现溶血磷脂如1-棕榈酰-GPA(甘油-3-磷酸)、1-硬脂酰-GPS(甘油-3-磷酸丝氨酸)、1-棕榈酰-GPI(甘油磷酸肌醇)、1-硬脂酰-GPI和1-油酰-GPI在激活的血小板中上调。我们推测血小板激活可能与一碳代谢有关,一碳代谢是一组生化途径,涉及氨基酸中一碳单位的转移和使用,用于细胞过程,包括核苷酸和溶血磷脂合成。相应地,基于途径富集和基于网络的优先级排序,氨基酸代谢中的代谢物,包括丝氨酸、谷氨酸和支链氨基酸途径在激活的血小板中上调,这可能由高水平的糖酵解中间体补充。
静息和激活血小板的代谢分析表明,糖酵解和一碳代谢是支持血小板激活所必需的。